Skip to main content

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Top User Menu

  • CME
  • Register
  • Login
Advertisement

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum
  • News (125)
  • CME (3)
Videos
Podcast
  • Daily News
  • Conference News
  • Editor's Corner
  • Industry News
  • CV Team Dispatch
  • Features
  • Off Script
  • ESC (14)
  • AHA (12)
  • ACC (9)
  • ISC (5)
  • CRT (2)
  • EuroPCR (1)
  • HFSA (1)
  • TCT (1)
  • VIVA (1)
  • Clinical Pharma (90)
  • Coronary (49)
  • Policy & Practice (45)
  • Heart Rhythm (39)
  • Heart Failure (37)
  • Atrial Fibrillation (29)
  • CAD Pharma (28)
  • Prevention (26)
  • Endovascular (25)
  • Heart Rhythm Pharma (22)
  • Structural Heart (22)
  • Stroke (20)
  • Diabetes (18)
  • Heart Failure Pharma (16)
  • Imaging & Physiology (15)
  • ACS/AMI (11)
  • Venous (11)
  • Cath Lab (9)
  • Guidelines (8)
  • Obesity (8)
  • Popliteal/Infrapopliteal (7)
  • Public Health (7)
  • Renovascular (7)
  • Aortic Valve (6)
  • COVID-19 (5)
  • DES/BRS/DCB (5)
  • Lipids (5)
  • Approvals (4)
  • Hypertension (4)
  • Ablation (3)
  • Alerts (3)
  • Angiography/QCA (2)
  • Cardiac Surgery (2)
  • Congenital (2)
  • Dilated Cardiomyopathy (2)
  • Hemodynamics (2)
  • Hypertrophic Cardiomyopathy (2)
  • Left Atrial Appendage (2)
  • Plaque Modification (2)
  • Quality (2)
  • Women's Heart (2)
  • Carotid (1)
  • CT/CT-FFR (1)
  • CTO (1)
  • Femoral (1)
  • Pacing/ICDs (1)
  • Training (1)
  • Tricuspid Valve (1)
  • Vascular Access/Closure (1)
  • (-) Clinical Cardiology (128)
  • 2025 (9)
  • 2024 (15)
  • 2023 (6)
  • 2022 (13)
  • 2021 (19)
  • 2020 (13)
  • 2019 (10)
  • 2018 (9)
  • 2017 (11)
  • 2016 (16)
Displaying 1 - 20 of 128
Sort: Relevancy | Date
OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding
News Conference News ISC 2026

OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding

Todd Neale
Todd Neale
February 09, 2026
Even With Optimized GDMT, HFrEF Prognosis Remains Dire
News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan
Michael O'Riordan
January 30, 2026
Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure
News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan
Michael O'Riordan
December 30, 2025
Andexanet Alfa Pulled From US Market
News Daily News

Andexanet Alfa Pulled From US Market

Todd Neale
Todd Neale
December 22, 2025
Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE
News Daily News

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

Michael O'Riordan
Michael O'Riordan
November 24, 2025
Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN
News Conference News AHA 2025

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

Michael O'Riordan
Michael O'Riordan
November 08, 2025
What’s Going to Be Hot at AHA 2025?
News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan
Michael O'Riordan
November 05, 2025
Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding
News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown
L.A. McKeown
May 16, 2025
RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI
News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan
Michael O'Riordan
April 02, 2025
What’s Going to Be Hot at ACC 2025?
News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan
Michael O'Riordan
March 26, 2025
Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF
News Daily News

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

Michael O'Riordan
Michael O'Riordan
March 03, 2025
More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin
News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

L.A. McKeown
L.A. McKeown
February 14, 2025
Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations
News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown
L.A. McKeown
January 31, 2025
TCTMD’s Top 10 Most Popular Stories for January 2025
News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2025

Shelley Wood
Shelley Wood
January 31, 2025
Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit
News Daily News

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Michael O'Riordan
Michael O'Riordan
January 13, 2025
FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity
News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown
L.A. McKeown
December 13, 2024
Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F
News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan
Michael O'Riordan
November 16, 2024
SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity
News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan
Michael O'Riordan
November 16, 2024
FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?
News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan
Michael O'Riordan
October 02, 2024
FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients
News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan
Michael O'Riordan
September 01, 2024

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next page ››
  • Last page Last »
Advertisement
Become a Member

Register for TCTMD ®

Membership Plans
Sign Up for Our Newsletter

Receive the the latest news, research, and presentations from major meetings right to your inbox.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives. For more information, visit http://www.crf.org.

Main Navigation

  • News
  • Conferences
  • Slides
  • Videos
  • Podcasts
  • Fellows Forum
  • CV Team Forum
  • CME

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Footer

  • Advertising & Sponsorships
  • About TCTMD ®
  • FAQs
  • Editorial Policy
  • Contact Us
  • About CRF ®
Digital Health Awards Winner - Spring 2017 eHealthcare Leadership Awards - 2018 Winner HON Code Certified
Copyright © 2026. TCTMD ® All rights reserved.
  • Privacy Policy
  • Terms of Use
Created by Constructive
Sign In

New at TCTMD? Register today!

Forgot Password

Forgot Your Password?

Enter the email you used to register to reset your password.

Search TCTMD
cme
CME TITLE
Sign up for our newsletter

Sign up to receive the most important cardiovascular news, research, and major meeting presentations.

Address
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum

Top User Menu

  • CME
  • Register
  • Login

Search TCTMD

Submit an Event
< >

Become a PREMIUM MEMBER or LOG IN to view exclusive content

This content is available for meeting attendees and/or Platinum Members

REGISTER for free or LOG IN to view this content

Now Playing